, decision-makers must have faith in risk-prediction tools and model-based cost-effectiveness analyses for people at different … statins and bisphosphonates; examine the effect of competing risks and direct treatment disutility on cost effectiveness of …-worst scaling (n=631).Updated cost-effectiveness analysis generates more quality-adjusted life-years in people with below …